Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
07/2010
07/21/2010EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis
07/21/2010EP1474121B1 Synergistic association of (-)- gossypol with docetaxel or paclitaxel for cancer treatment
07/21/2010EP1276896B1 Epitope synchronization in antigen presenting cells
07/21/2010EP1143970B1 Pyridine compounds, use and preparation thereof
07/21/2010EP1079825B1 Compounds that inhibit the binding of integrins to their receptors
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/21/2010CN101784566A Cytotoxicity mediation of cells evidencing surface expression of cd9
07/21/2010CN101784552A 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
07/21/2010CN101784551A bicycloaniline derivative
07/21/2010CN101784550A Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
07/21/2010CN101784545A Compounds useful as raf kinase inhibitors
07/21/2010CN101784544A thiadiazinone derivatives
07/21/2010CN101784543A Indole and indazole compounds as an inhibitor of cellular necrosis
07/21/2010CN101784539A 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
07/21/2010CN101784538A Pyridoneamide derivatives as focal adhesion kinase (FAK) inhibitors and their use for the treatment of cancer
07/21/2010CN101784523A Novel compounds, compounds that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
07/21/2010CN101784278A Purin derivatives for use in the treatment of FAB-related diseases
07/21/2010CN101784277A Treatment of pediatric tumors
07/21/2010CN101781636A Proliferous type recombination oncolytic adenovirus containing 11-type adenovirus cilia protein gene, construction method and application thereof
07/21/2010CN101781370A Recombination fusion protein of soluble vascular endothelial growth factor receptor and application thereof
07/21/2010CN101781369A Recombinant human arginase fusion protein and application thereof
07/21/2010CN101781357A Polypeptide for detecting human cancer cells, and application thereof
07/21/2010CN101781355A Method for preparing limonin, composition and application thereof
07/21/2010CN101781353A 20(S)-ginsenoside Rh2 derivatives for regulating and controlling ER Alpha/ER Beta-TNF Alpha channel as well as preparation and anti-tumor application thereof
07/21/2010CN101781348A Stable protein kinase activator, preparation method thereof and use
07/21/2010CN101781347A Polymorphic substances of decitabine and medical compositions
07/21/2010CN101781325A Gallium salicylaldehyde amino acid Schiff base quaternary coordination compound, preparation method and application thereof
07/21/2010CN101781304A Tetrahydroisoquinoline compound and preparation method and application thereof
07/21/2010CN101781285A Quinazoline derivates, preparation method thereof and pharmaceutical application thereof
07/21/2010CN101781283A Thioredoxin reductase inhibiter compounds and preparation method and application thereof
07/21/2010CN101781269A 4-tertiary butyl-2-(nitrobenzyl imino) thiazole derivative as well as preparation method and application thereof
07/21/2010CN101780286A Chemotactic factor receptor CXCR4 non-peptide antagonist medicaments for radiodiagnosis and treatment
07/21/2010CN101780283A Application of signal adjusting protein alpha in preparation of DC vaccine for preventing and treating tumors
07/21/2010CN101780282A Chitosan-carrying mitomycin nano targeting preparation and preparation method thereof
07/21/2010CN101780271A Medicinal composition of endotoxin and lectin and application thereof
07/21/2010CN101780259A Traditional Chinese medicine for treating gastric cancer
07/21/2010CN101780256A Production method for extracting zedoary turmeric oil by using supercritical CO2
07/21/2010CN101780254A Traditional Chinese medicine compound for treating intestinal tumor and preparation method thereof
07/21/2010CN101780239A Four-herb anti-tumor and anti-AIDS soft capsules and preparation process thereof
07/21/2010CN101780232A Coix seed oil proliposome and preparation method thereof
07/21/2010CN101780204A Traditional Chinese medicine for treating tumors - quick-effect scabrousstem greenbrier rhizome and caulis mayteni root-bark powder
07/21/2010CN101780197A Drug for treating gastric cancer
07/21/2010CN101780187A Medicine for treating breast cancer
07/21/2010CN101780182A Application of nutrition combination in preparation of medicine for restoring mitochondrial damage
07/21/2010CN101780181A Nitric oxide free radical health care product
07/21/2010CN101780150A Plant extract and pharmaceutical composition for treating cough and preparation method thereof
07/21/2010CN101780136A Medicine and food dual-purpose traditional Chinese medicine composition with anti-tumor activity and immunoregulation effect and application thereof
07/21/2010CN101780092A Compounds and methods for delivery of prostacyclin analogs
07/21/2010CN101780074A Anti-lung cancer pharmaceutical composition
07/21/2010CN101780068A Application of jungermanniaceae D in preparing anti-tumor medicaments and anti-tumor multi-drug resistance reversing medicaments
07/21/2010CN101780066A Usage of isothiocyanate in preparing medicine for preventing from tumor invasion and metastasis
07/21/2010CN101780063A Application of amitriptyline
07/21/2010CN101780043A Preparation method of sanguinarine liposome with acid sensitivity
07/21/2010CN101780042A Taxol nano targeting slow-release long-circulating liposome and preparation method thereof
07/21/2010CN101780041A Polymer coated vitamin E liposome and preparation method thereof
07/21/2010CN101780033A Pre-filled recombinant human interferon injection
07/21/2010CN101612360B Medicine for treating hepatitis, hepatocirrhosis and liver cancer
07/21/2010CN101461942B Dendritic cell vaccine carrying recombinant human HSP70 polypeptide complexes, preparation method and application
07/21/2010CN101380310B Composition of bFGF modified liposome and shRNA expression vector targeting human VEGF gene and preparation method thereof
07/21/2010CN101249070B 2-methoxy estradiol vena nano emulsions
07/21/2010CN101233838B Method for inducing spider to generate antibiotic activity substance
07/21/2010CN101152193B Application of 1,3,4-3-O-gallnut acyl-6-O-coffee acyl-beta-D-glucopyranose in preparing antineoplastic medicament
07/21/2010CN101152192B Application of 1,3-2-O-gallnut acyl 1-4,6-(S)-HHDP-beta-D-glucopyranose in preparing antineoplastic medicament
07/21/2010CN101104644B Preparation for polysaccharide selenite and application thereof
07/21/2010CN101062028B Combination including taxanes, the preparing method and the use thereof
07/21/2010CN101007011B Ginsenoside Rh2 self-emulsifying composition and its preparation method
07/20/2010US7759526 Pharmaceutical compositions comprising cannabidiol derivatives
07/20/2010US7759494 Paclitaxel or docetaxel synthesis and claimed intermediates; purity; coupling 7,10-diprotected intermediates 7-O-(2-haloacyl)baccatin III or 7,10-O-di-(2-haloacyl)-10-deacetylbaccatin III to 3-[(2-alkyl/aryl-2-trialkylsilyl)ethoxy-carbonyl]-4-aryl-2-substituted-1,3-oxazolidine-5-carboxylic acid
07/20/2010US7759488 Monoazole ligand platinum analogs
07/20/2010US7759486 2,4,5-Trisubstituted pyrimidine compounds
07/20/2010US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
07/20/2010US7759396 Using alpha-ketoglutarate , mono- or divalent metal salts of alpha-ketoglutarate and/or ornithine of alpha-ketoglutarate; acting specifically on neoplastic cells with the simultaneous protective activity on the normal cells; synergic action with antineoplastic drugs and simultaneous protective activity
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759380 Substituted pyrrolines as kinase inhibitors
07/20/2010US7759375 Epothilones C, D, E, and F, preparation and compositions
07/20/2010US7759371 Anticancer, antitumor agents, using 2-amino-5-phenyl- (1,3,4)thiadiazoline compounds
07/20/2010US7759361 treating a cancer, autoimmune diseases and cardiovscular disorders comprising administering drugs such as Isobutyric acid 2-isobutyryloxymethyl-3-oxo-1-aza-bicyclo[2.2.2]oct-ylmethyl ester; antiproliferative agents
07/20/2010US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
07/20/2010US7759347 polo-like kinase inhibitors used as antiproliferative and antitumor agents
07/20/2010US7759345 ecteinascidins used for treating lung, colon, kidney, prostate, ovarian, breast and pancreatic cancers, leukaemia or melanoma
07/20/2010US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
07/20/2010US7759338 Programmed cell death, autoimmunity, inflammation, hyperproliferation; easy formulation, shelf life
07/20/2010US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus
07/20/2010US7759323 Highly purified antiendotoxin compound
07/20/2010US7759313 Induction method for cell differentiation
07/20/2010US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor
07/20/2010US7759078 Diagnosis and treatment of cancer
07/20/2010US7759068 Eukaryotic cells are treated with a polynucleotide which encodes a polypeptide which inhibits the expression or the function of proteins synthesized or secreted by tumors, and thus inhibits the increase in tissue volume or the metastasis of the tumors; for prostatic tissue
07/20/2010US7758899 Pharmaceutical compositions and their use in the treatment of neoplastic disease
07/20/2010US7758861 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions
07/20/2010US7758852 OX40R binding agents
07/20/2010CA2532049C Isethionate salt of a selective cdk4 inhibitor
07/20/2010CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
07/20/2010CA2447865C Novel sulfonic acid derivatives
07/20/2010CA2421339C Novel polypeptides and nucleic acids encoding the same
07/20/2010CA2411831C Pharmaceutical compositions comprising cannabidiol derivatives
07/20/2010CA2399001C Integrin expression inhibitor
07/20/2010CA2366694C Process for the preparation of cyclo (asp-dphe-nmeval-arg-gly)
07/20/2010CA2322487C Novel prodrugs for phosphorus-containing compounds
07/20/2010CA2266908C O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
1 ... 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 ... 2211